DNTH vs KR · rev $6.2M vs P/E 19, rev $147.12B
Dianthus Therapeutics Inc. (DNTH) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
DNTH currently screens at market cap $4.40B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the DNTH and KR stock pages for the full models.
Not investment advice.